PCI’s Philly Tech Week Panel Featured in Technical.ly
PCI, Pennovation Works and Philadelphia Alliance for Capital & Technologies (PACT) hosted the “Innovate & Inspire: Research Panel & Pitch Competition” in May.
Dr. Jim Wilson’s Gene Therapy Work with Gemma Biotherapeutics Profiled by the Philadelphia Inquirer
Gemma Biotherapeutics was co-founded in 2024 by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Cerespectus and Vasowatch Join HiveBio’s Inaugural Cohort
HiveBio has selected its inaugural cohort of underrepresented biotech founders.
Cerespectus Accepted into Science Center’s Capital Readiness Program
Cerespectus was co-founded by Bryan Pukenas, MD, Associate Professor of Radiology in Penn Medicine.
MavriX Bio Announces FDA Clearance for Gene Therapy Trial
MavriX will initiate a clinical trial of a gene therapy for Angelman syndrome.
Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Autoimmune Disease
Capstan Therapeutics, a biotechnology company spun out of Penn, has initiated its Phase 1 trial of an in vivo CAR-T therapy.
REGENXBIO’s Gene Therapy Updates for Hunter Syndrome and DMD
REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Penn Startup Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform
Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,
Philadelphia Ranks #13 Globally, Climbing Up 12 Spots, in 2025 Global Startup Ecosystem Report
The 2025 Global Startup Ecosystem Report has been released.
Three Penn I-Corps Teams Participated in State-wide Pitch Event
Three Penn I-Corps teams participated in the SmartTech Tournament on April 10 and 11, 2025 as part of the Invent Penn State Venture & IP Conference.